16 Cavendish Ct.
8 articles with Celdara Medical
Celdara Medical and the University of Vermont Secure NIH Funding to Improve Pandemic Preparedness and Response
Celdara Medical, LLC announced that the National Institute of Allergy and Infectious Disease of the National Institutes of Health has awarded it a two-year Small Business Technology Transfer Research grant to fund the development of a novel, broad-spectrum therapeutic/prophylactic against RNA viruses, including SARS-CoV-2, SARS, Ebola, influenza, and pathogenic arenaviruses.
Celdara Medical announced the launch of the Pandemic Security Initiative's Scientific Advisory Board, a group of outstanding scientists and infectious disease experts.
Grant Enables Development of Innovative Medicines Against Future Pandemic Threats [12-August-2020] CAMBRIDGE, Mass. and LEBANON, N.H. and NEW YORK, Aug. 12, 2020 /PRNewswire/ -- Celdara Medical ("Celdara") announced that the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) has awarded a Small Business Innovatio
Celdara Medical ("Celdara") today announced the launch of its Pandemic Security Initiative, harnessing the resources needed to prepare the nation for future infectious disease pandemics.
5/30/2019Here's a preview of just a handful of opportunities, companies and speakers and what they’re presenting.
NIH Awards $1.7 Million Grant For Celdara Medical And Pulmatrix To Develop An Inhaled Biologic Treatment For Idiopathic Pulmonary Fibrosis
Daiichi Sankyo, Inc., Virtici And Celdara Medical Announce Collaboration To Identify And Progress High Potential Therapeutics